Financial Services
Live Price
Offline$46.61
+1.84% today
1Y Change
+140.83%
Window
Jun 30, 2025 → Jun 26, 2026
Coverage: 249 bars · Jun 30, 2025 → Jun 26, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
ProFunds Biotechnology UltraSector Fund Service Class (BIPSX) is a Financial Services stock with a market cap of $150.00M. The stock last traded around $46.61 and up 140.8% across the available one-year price window (Jun 30, 2025 → Jun 26, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. Stock Foundry combines BIPSX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
BIPSX is 122.84 pts ahead over the shared 1Y window.
BIPSX had 6.19 pts deeper max drawdown than SPY.
BIPSX beat SPY in 2 of 2 calendar years shown and trailed in 0.
BIPSX
+140.83%
Normalized return
SPY
+17.99%
S&P 500
Excess Return
+122.84 pts
Relative to SPY
BIPSX Max Drawdown
-15.32%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for BIPSX and SPY.
| Year | BIPSX | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | +39.57% | +6.71% | +32.86 pts | BIPSX |
| 2025 | +73.00% | +11.19% | +61.80 pts | BIPSX |
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
0.0%
Net Margin
0.0%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.